GLP-2通过PI3K/AKT/FOXO1信号通路作用于骨质细胞,从而减轻绝经后的骨质疏松症,从而降低FGF23表达的调节
Kefen Wu1, Weiying Ren1, Bing'er Xu1
1Department of Geriatrics, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai, 200032, People's Republic of China.
葡萄糖类-2 (GLP-2) 治疗通过激活PI3K/AKT/FOXO1通路来改善骨质疏松症中的骨密度. 这一过程降低了纤维细胞生长因子23 (FGF23) 的调节,为骨质疏松症提供了一个新的治疗点.
科学领域:
- 内分泌学 在内分泌学.
- 骨生物学 骨生物学 骨生物学
- 分子信号传输的方法
背景情况:
- 类似葡萄糖-2 (GLP-2) 促进骨的形成和质量.
- 异常的纤维细胞生长因子23 (FGF23) 表达与骨质疏松症有关.
- 通过PI3K/AKT/FOXO1通路调节FGF23,GLP-2可以抵消骨质疏松症.
研究的目的:
- 研究GLP-2改善绝经后骨质疏松症的机制.
- 为了确定GLP-2是否通过降低FGF23表达的调节来发挥骨保护作用.
- 阐明PI3K/AKT/FOXO1信号通路在GLP-2对骨质疏松症作用中的作用.
主要方法:
- 建立了一个卵巢切除 (OVX) 鼠标模型来治疗绝经后骨质疏松症.
- 向OVX小鼠注射GLP-2,PI3K抑制剂LY294002,或两者.
- 评估了骨矿物质密度,骨微观结构,Runx2和FGF23表达;利用RNA测序和体外骨质细胞研究.
主要成果:
- OVX小鼠显示骨矿物质密度降低和微观结构改变,FGF23.3增加.
- GLP-2治疗显著改善了骨矿物质密度和微观结构,同时降低了FGF23.
- GLP-2激活了骨质母细胞中的PI3K/AKT/FOXO1信号,减少了FGF23的表达,PI3K抑制逆转了这一效应.
结论:
- GLP-2通过激活骨质细胞中的PI3K/AKT/FOXO1通路来改善绝经后的骨质疏松症.
- 这种激活导致FGF23的下调,有助于骨保护.
- 这些发现表明GLP-2是骨质疏松症的潜在治疗剂,向已识别的分子途径.
更多相关视频
07:20Author Spotlight: Integrating Traditional Chinese Medicine with Modern Pharmacology and Genomics for Assessing Postmenopausal Osteoporosis in Mice
Published on: August 23, 2024
08:53Drug Treatment and In Vivo Imaging of Osteoblast-Osteoclast Interactions in a Medaka Fish Osteoporosis Model
Published on: January 1, 2017
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Hedgehog Signaling Pathway
Insulin: The Receptor and Signaling Pathways
IP3/DAG Signaling Pathway
